EN
0
Home > Products > Pharmaceuticals & Life Science > Pharmaceutical Intermediates > ethyl 4-(((2R,3R,4S,5R,6S)-4,5-bis(benzo[d][1,3]dioxol-5-ylcarbamoyloxy)-2-(hydroxymethyl)-6-methoxy-tetrahydro-2H-pyran-3-yloxy)carbonyl)benzoate
ethyl 4-(((2R,3R,4S,5R,6S)-4,5-bis(benzo[d][1,3]dioxol-5-ylcarbamoyloxy)-2-(hydroxymethyl)-6-methoxy-tetrahydro-2H-pyran-3-yloxy)carbonyl)benzoate structure, CAS 1137359-47-7

ethyl 4-(((2R,3R,4S,5R,6S)-4,5-bis(benzo[d][1,3]dioxol-5-ylcarbamoyloxy)-2-(hydroxymethyl)-6-methoxy-tetrahydro-2H-pyran-3-yloxy)carbonyl)benzoate

CAS Number1137359-47-7

SynonymsReferences

Molecular FormulaC33H33N3O15

Molecular Weight711.64

Purity

Density1.5±0.1 g/cm3

Boiling Point757.6±60.0 °C at 760 mmHg

Melting Point

Flash Point

Appearance

EINECS

MSDSChineseEnglish

Symbol

Signal Word

Cat. No.: 2A-2187898 Purity:
Change View

Please Login or Create an Account to: See VlP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

Inquiry

Quality Control of [ 1137359-47-7 ] SDS Specification MoL

COA NMR CNMR HPLC LC-MS
Chemical & Physical Properties
CAS Number1137359-47-7
Catalog No.2A-2187898
Chinese NameBRD7552
SynonymsReferences
Molecular FormulaC33H33N3O15
Molecular Weight711.64
Density1.5±0.1 g/cm3
Boiling Point757.6±60.0 °C at 760 mmHg
Storage Condition-20℃
ApplicationBRD7552 is an inducer of the transcription factor PDX1 and increases insulin expression.
PubChem ID47647222
MDL NumberC33H33N3O15
SMILESCCOC(=O)c1ccc(NC(=O)OC2C(CO)OC(OC)C(OC(=O)Nc3ccc4c(c3)OCO4)C2OC(=O)Nc2ccc3c(c2)OCO3)cc1
InChIInChI=1S/C33H33N3O15/c1-3-43-29(38)17-4-6-18(7-5-17)34-31(39)49-26-25(14-37)48-30(42-2)28(51-33(41)36-20-9-11-22-24(13-20)47-16-45-22)27(26)50-32(40)35-19-8-10-21-23(12-19)46-15-44-21/h4-13,25-28,30,37H,3,14-16H2,1-2H3,(H,34,39)(H,35,40)(H,36,41)/t25-,26-,27+,28-,30+/m1/s1
InChI KeyAAOLIMLEFKWKOY-IXMSMLDRSA-N
Transport InfoProduct name: BRD7552
Related Products in Pharmaceutical Intermediates
N-[(2S,3R,4R,5S,6R)-5-hydroxy-6-(hydroxymethyl)-2,4-bis(phenylmethoxy)oxan-3-yl]acetamide14146-27-12A-2187883
(3R,4S,5R,6R)-6-(Hydroxymethyl)tetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate65620-65-72A-2187891
(3R,4S,5S,6S)-6-Formyltetrahydro-2H-pyran-2,3,4,5-tetrayl tetraacetate67968-62-12A-2187892
(2S,3R,4S,5R,6R)-5-Hydroxy-2-methoxy-6-((trityloxy)methyl)tetrahydro-2H-pyran-3,4-diyl diacetate53717-00-32A-2187895
(2R,3S,4S,5R,6R)-2-(Hydroxymethyl)-6-((triphenylphosphoranylidene)amino)tetrahydro-2H-pyran-3,4,5-triol100639-11-02A-2187896
(3R,4S,5R,6R)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)piperidin-2-one77174-08-42A-2187905
6,11-Di-10H-phenoxazin-10-yldibenzo[f,h]quinoxaline1621601-01-12A-2187968
1-((2R,3S,4S)-4-fluoro-3-hydroxy-5-Methylene-tetrahydro-furan-2-yl)-1H-pyriMidine-2,4-dione1145869-42-62A-2187995
-((2R,3S,4S,5S)-4-fluoro-3-hydroxy-5-iodoMethyl-tetrahydro-furan-2-yl)-1H-pyriMidine-2,4-dione1145869-41-52A-2188001
(1R, 4R, 5S)-4-hydroxyMethyl-cyclohex-2-en-1,5-diol328926-81-42A-2188007
Browse all Pharmaceutical Intermediates products »
Contact Us

Phone:

630-322-8886

630-322-8887

Email:

[email protected]

Office Locations:

Chicago, IL, USA

San Francisco, CA, USA